Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections

Brinker A, Weber E, Stoll D, Voigt J, Muller A, Sewald N, Jung G, Wiesmuller KH, Bohley P (2000)
EUROPEAN JOURNAL OF BIOCHEMISTRY 267(16): 5085-5092.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ;
Abstract / Bemerkung
By screening a combinatorial pentapeptide amide collection in an inhibition assay, we systematically evaluated the potential of 19 proteinogenic amino acids and seven nonproteinogenic amino acids to serve as building blocks for inhibitors of human cathepsin L. Particularly efficient were aromatic, bulky, hydrophobic amino-acid residues, especially leucine, and positively charged residues, especially arginine. Building blocks for potential inhibitory peptides were combined by random selection from their activity pattern. This random approach for the design of inhibitors was introduced to compensate for the inaccuracy induced by shifted docking of combinatorial compound collections at the active center of cathepsin L. Thereby, we obtained structurally defined pentapeptide amides which inhibited human cathepsin L at nanomolar concentrations. Among the most potent novel inhibitors, one peptide, RKLLW-NH2, shares the amphiphilic character of the nonamer fragment VMNGLQNRK of the autoinhibitory, substrate-like, but reverse-binding prosegment of human cathepsin L which blocks the active center of the enzyme. Obviously, RKLLW-NH2 carries the functions that are important for enzyme-peptide interaction in a condensed form. This hypothesis was confirmed by structure-activity studies using truncated and modified pentapeptides.
Erscheinungsjahr
Zeitschriftentitel
EUROPEAN JOURNAL OF BIOCHEMISTRY
Band
267
Ausgabe
16
Seite(n)
5085-5092
ISSN
PUB-ID

Zitieren

Brinker A, Weber E, Stoll D, et al. Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections. EUROPEAN JOURNAL OF BIOCHEMISTRY. 2000;267(16):5085-5092.
Brinker, A., Weber, E., Stoll, D., Voigt, J., Muller, A., Sewald, N., Jung, G., et al. (2000). Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections. EUROPEAN JOURNAL OF BIOCHEMISTRY, 267(16), 5085-5092. doi:10.1046/j.1432-1327.2000.01570.x
Brinker, A., Weber, E., Stoll, D., Voigt, J., Muller, A., Sewald, N., Jung, G., Wiesmuller, K. H., and Bohley, P. (2000). Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections. EUROPEAN JOURNAL OF BIOCHEMISTRY 267, 5085-5092.
Brinker, A., et al., 2000. Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections. EUROPEAN JOURNAL OF BIOCHEMISTRY, 267(16), p 5085-5092.
A. Brinker, et al., “Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections”, EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 267, 2000, pp. 5085-5092.
Brinker, A., Weber, E., Stoll, D., Voigt, J., Muller, A., Sewald, N., Jung, G., Wiesmuller, K.H., Bohley, P.: Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections. EUROPEAN JOURNAL OF BIOCHEMISTRY. 267, 5085-5092 (2000).
Brinker, A, Weber, E, Stoll, D, Voigt, J, Muller, A, Sewald, Norbert, Jung, G, Wiesmuller, KH, and Bohley, P. “Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections”. EUROPEAN JOURNAL OF BIOCHEMISTRY 267.16 (2000): 5085-5092.

9 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Lysosomal membrane permeabilization is involved in oxidative stress-induced apoptotic cell death in LAMP2-deficient iPSCs-derived cerebral cortical neurons.
Law CY, Siu CW, Fan K, Lai WH, Au KW, Lau YM, Wong LY, Ho JCY, Lee YK, Tse HF, Ng KM., Biochem Biophys Rep 5(), 2016
PMID: 28955840
Structural insights into substrate binding by PvFKBP35, a peptidylprolyl cis-trans isomerase from the human malarial parasite Plasmodium vivax.
Alag R, Balakrishna AM, Rajan S, Qureshi IA, Shin J, Lescar J, Grüber G, Yoon HS., Eukaryot Cell 12(4), 2013
PMID: 23435727
A novel photoaffinity-based probe for selective detection of cathepsin L active form.
Torkar A, Bregant S, Devel L, Novinec M, Lenarčič B, Lah T, Dive V., Chembiochem 13(17), 2012
PMID: 23125066
Protective effects of a cysteine proteinase propeptide expressed in transgenic soybean roots.
Marra BM, Souza DS, Aguiar JN, Firmino AA, Sarto RP, Silva FB, Almeida CD, Cares JE, Continho MV, Martins-de-Sa C, Franco OL, Grossi-de-Sa MF., Peptides 30(5), 2009
PMID: 19428757
Crystallographic structure of the tetratricopeptide repeat domain of Plasmodium falciparum FKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide.
Alag R, Bharatham N, Dong A, Hills T, Harikishore A, Widjaja AA, Shochat SG, Hui R, Yoon HS., Protein Sci 18(10), 2009
PMID: 19691130
Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function.
Marneros AG, Keene DR, Hansen U, Fukai N, Moulton K, Goletz PL, Moiseyev G, Pawlyk BS, Halfter W, Dong S, Shibata M, Li T, Crouch RK, Bruckner P, Olsen BR., EMBO J 23(1), 2004
PMID: 14685281

37 References

Daten bereitgestellt von Europe PubMed Central.

Cathepsin L. A new proteinase from rat-liver lysosomes.
Kirschke H, Langner J, Wiederanders B, Ansorge S, Bohley P., Eur. J. Biochem. 74(2), 1977
PMID: 15835
Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
Carmona E, Dufour E, Plouffe C, Takebe S, Mason P, Mort JS, Menard R., Biochemistry 35(25), 1996
PMID: 8679567
Proteinases 1: lysosomal cysteine proteinases.
Kirschke H, Barrett AJ, Rawlings ND., Protein Profile 2(14), 1995
PMID: 8771190
Surface activation of pro-cathepsin L.
Mason RW, Massey SD., Biochem. Biophys. Res. Commun. 189(3), 1992
PMID: 1482371
Participation of cathepsin L on bone resorption.
Kakegawa H, Nikawa T, Tagami K, Kamioka H, Sumitani K, Kawata T, Drobnic-Kosorok M, Lenarcic B, Turk V, Katunuma N., FEBS Lett. 321(2-3), 1993
PMID: 8477857
Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
Goretzki L, Schmitt M, Mann K, Calvete J, Chucholowski N, Kramer M, Gunzler WA, Janicke F, Graeff H., FEBS Lett. 297(1-2), 1992
PMID: 1551416
Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis.
Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson-Hamilton M, Hamilton RT, McGhee JR, Fassbender HG, Gay S., Matrix 10(6), 1990
PMID: 2084514
Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells.
Yagel S, Warner AH, Nellans HN, Lala PK, Waghorne C, Denhardt DT., Cancer Res. 49(13), 1989
PMID: 2731177
Gene regulation and extracellular functions of procathepsin L.
Ishidoh K, Kominami E., Biol. Chem. 379(2), 1998
PMID: 9524064
Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.
Wurl P, Taubert H, Meye A, Dansranjavin T, Weber E, Gunther D, Berger D, Schmidt H, Dralle H, Rath FW., Virchows Arch. 430(3), 1997
PMID: 9099979
Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.
Weber E, Gunther D, Laube F, Wiederanders B, Kirschke H., J. Cancer Res. Clin. Oncol. 120(9), 1994
PMID: 8045924
Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.
Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort JS, Cygler M., EMBO J. 15(20), 1996
PMID: 8896443
The crystal structure of human cathepsin L complexed with E-64.
Fujishima A, Imai Y, Nomura T, Fujisawa Y, Yamamoto Y, Sugawara T., FEBS Lett. 407(1), 1997
PMID: 9141479
Revised definition of substrate binding sites of papain-like cysteine proteases.
Turk D, Guncar G, Podobnik M, Turk B., Biol. Chem. 379(2), 1998
PMID: 9524065
Action of cathepsin L on the oxidized B-chain of bovine insulin.
Kargel HJ, Dettmer R, Etzold G, Kirschke H, Bohley P, Langner J., FEBS Lett. 114(2), 1980
PMID: 6993230
Action of rat liver cathepsin L on glucagon.
Kargel HJ, Dettmer R, Etzold G, Kirschke H, Bohley P, Langner J., Acta Biol. Med. Ger. 40(9), 1981
PMID: 7340337
Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
Lalmanach G, Serveau C, Brillard-Bourdet M, Chagas JR, Mayer R, Juliano L, Gauthier F., J. Protein Chem. 14(8), 1995
PMID: 8747425
A new, sensitive fluorogenic substrate for papain based on the sequence of the cystatin inhibitory site.
Gauthier F, Moreau T, Lalmanach G, Brillard-Bourdet M, Ferrer-Di Martino M, Juliano L., Arch. Biochem. Biophys. 306(2), 1993
PMID: 8215429
Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Moroder L., FEBS Lett. 421(1), 1998
PMID: 9462845
Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.
Gallop MA, Barrett RW, Dower WJ, Fodor SP, Gordon EM., J. Med. Chem. 37(9), 1994
PMID: 8176700
Organic chemistry on solid supports
Früchtel, Angew. Chem. Int. ed. Eng. 35(), 1996
General method for rapid synthesis of multicomponent peptide mixtures
Furka, Int. J. Peptide Protein Res. 37(), 1991
Mixture-based synthetic combinatorial libraries.
Houghten RA, Pinilla C, Appel JR, Blondelle SE, Dooley CT, Eichler J, Nefzi A, Ostresh JM., J. Med. Chem. 42(19), 1999
PMID: 10508425
New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library.
Fleckenstein B, Kalbacher H, Muller CP, Stoll D, Halder T, Jung G, Wiesmuller KH., Eur. J. Biochem. 240(1), 1996
PMID: 8797837

Wiesmüller, 1996
Multiple peptide synthesis methods and their applications
Jung, Angew. Chem. Int. ed. Eng. 31(), 1992

AUTHOR UNKNOWN, 0
Monoclonal antibodies against cathepsin L and procathepsin L of different species.
Weber E, Bahn H, Gunther D., Hybridoma 16(2), 1997
PMID: 9145318
Cathepsin B, Cathepsin H, and cathepsin L.
Barrett AJ, Kirschke H., Meth. Enzymol. 80 Pt C(), 1981
PMID: 7043200
Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment.
Chagas JR, Ferrer-Di Martino M, Gauthier F, Lalmanach G., FEBS Lett. 392(3), 1996
PMID: 8774851

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 10931191
PubMed | Europe PMC

Suchen in

Google Scholar